BSE Live
Jan 07, 16:01Prev. Close
365.90
Open Price
364.15
Bid Price (Qty.)
383.70 (180)
Offer Price (Qty.)
387.20 (76)
NSE Live
Jan 07, 15:52Prev. Close
366.30
Open Price
363.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
384.05 (49)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 5.26 | 2.88 | |
| Diluted EPS (Rs.) | 5.26 | 2.88 | |
| Cash EPS (Rs.) | 7.72 | 4.71 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 21.86 | 19.17 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 21.86 | 19.17 | |
| Dividend / Share(Rs.) | 1.50 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 57.54 | 46.01 | |
| PBDIT/Share (Rs.) | 11.73 | 7.71 | |
| PBIT/Share (Rs.) | 9.35 | 5.97 | |
| PBT/Share (Rs.) | 7.61 | 3.81 | |
| Net Profit/Share (Rs.) | 5.26 | 2.88 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 20.38 | 16.75 | |
| PBIT Margin (%) | 16.24 | 12.96 | |
| PBT Margin (%) | 13.22 | 8.27 | |
| Net Profit Margin (%) | 9.14 | 6.25 | |
| Return on Networth / Equity (%) | 24.06 | 15.00 | |
| Return on Capital Employed (%) | 19.01 | 12.21 | |
| Return on Assets (%) | 6.34 | 3.89 | |
| Total Debt/Equity (X) | 1.29 | 1.53 | |
| Asset Turnover Ratio (%) | 69.41 | 62.36 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.70 | 2.17 | |
| Quick Ratio (X) | 0.71 | 0.93 | |
| Inventory Turnover Ratio (X) | 1.72 | 1.49 | |
| Dividend Payout Ratio (NP) (%) | 28.47 | 34.70 | |
| Dividend Payout Ratio (CP) (%) | 19.39 | 21.21 | |
| Earnings Retention Ratio (%) | 71.53 | 65.30 | |
| Cash Earnings Retention Ratio (%) | 80.61 | 78.79 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 927.71 | 442.37 | |
| EV/Net Operating Revenue (X) | 2.82 | 1.68 | |
| EV/EBITDA (X) | 13.84 | 10.04 | |
| MarketCap/Net Operating Revenue (X) | 2.08 | 0.92 | |
| Retention Ratios (%) | 71.52 | 65.29 | |
| Price/BV (X) | 5.47 | 2.21 | |
| Price/Net Operating Revenue | 2.08 | 0.92 | |
| Earnings Yield | 0.04 | 0.07 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y